Based on our hypothesis, we proceeded to evaluate GJB2 expression as a potential prognostic marker for ROS1-rearranged NSCLC, considering its upregulation compared to ALK+ and RET+ tumors, as well as normal adjacent lung tissue. Here, GJB2 is linked to non-small cell lung carcinoma.